MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Award Announcements & Progress Reports: Federal Contracts, Grants & Cooperative Agreements
2022: On Jan. 13, 2021, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contracts to Abbott Rapid Dx North America, LLC, iHealth Lab Inc., and Roche Diagnostics Corporation to purchase total of 380 million over-the-counter COVID-19 test kits.
Abbott Laboratories (NYSE:ABT)
Organization & Developments: Abbott
Parents
Abbott Laboratories (NYSE:ABT)
Children
* Its Freestyle Libre line of glucose monitors are among the most popular in the US
*Abbot: Brands
*Abbot: Primary Businesses
*Abbott Cardiovascular Systems, Inc.
*Abbott Diabetes Care Inc.
*Abbott Ireland
*Abbott's device portfolio is focused on diabetes care, cardiovascular (pacemakers, cardiac mapping), pain and movement products (spinal cord stimulation, deep brain stimulation), and a host of diagnostics products.
*Drug Eluting Stents (DES)
*ESPRIT BTK EVEROLIMUS ELUTING RESORBABLE SCAFFOLD SYSTEM
*I-STAT ALINITY SYSTEM
*I-STAT TBI CARTRIDGE WITH THE I-STAT ALINITY SYSTEM
*TRICLIP G4 SYSTEM
2006: R&D Investment: $2.3B (2006)
2010: Reata scores $450M in quick cash from Abbott pact (2010)
2011: Marvels of Medical Technology: Absorb Bioresorbable Vascular Scaffold (2011)
2013: ABBOTT AND ABBVIE: AN EXCITING NEW CHAPTER IN GLOBAL HEALTH (2014)
2014: Abbott Laboratories May Look To Expand Medical
2014: Can Flash Glucose Monitoring Disrupt Diabetes Care (and Revive Abbott’s Diabetes Business)?
2014: Will Abbott Rule the Diagnostics Market by 2019?
2016: Abbott Sues Alere for Breach of Contract
2016: This Is What Makes Abbott Laboratories Great - Abbott Laboratories (NYSE:ABT)
2017: Abbott, Bigfoot Biomedical collaborate on diabetes technologies
2017: VA_65--Abbott Catheters
2017: VA_J--Abbott iSTAT Service VAMC Minneapolis
2018: U.S. Army_65--I-Stat System
2018: U.S. Army_MEDCOM_Abbott Laser Ophthalmic Systems
2019: How Abbott's New Continuous Glucose Monitor Can Change The Company - Abbott Laboratories (NYSE:ABT)
2019: U.S. Army_Development of a Traumatic Brain Injury (TBI) Diagnostic Assay for the i-STAT_Abbot
2020: Abbott gets EUA for rapid $5 COVID-19 antigen test
2020: Abbott Laboratories_White House announces deal to provide 150 million rapid coronavirus tests
2020: Abbott, Tandem seal deal to combine CGM, insulin delivery tech
2021: DLA contracts Abbott to supply OTC antigen test kits_Abbott bags ~$119.5M contract for antigen test kikts
2022: Abbott awarded $1B US Army contract for COVID-19 antigen tests
2022: Abbott Laboratories: Good Execution And Attractive Valuation_ seekingalpha.com
2022: Abbott's concussion blood test helps predict death, disability after 6 months: study
2022: Abbott's Rough Patch: What Gives?_seekingalpha.com
2022: Abbott’s FreeStyle Libre linked to 67% drop in hospitalizations for Type 2 diabetes patients: study
2023: Abbott And AbbVie: 10 Years Of Blue Chip Outperformance, More To Come_ seekingalpha.com
2023: Abbott Laboratories Triumphs Over Challenges: A Tale Of Resilience
2023: Abbott Laboratories: One Of The Safest Dividend Growth Stocks On The Market_ seekingalpha.com
2023: Abbott Laboratories: The 3 Issues That Will Define 2023 Performance_seekingalpha
2024: A new rapid test produces lab quality results using whole blood to identify biomarkers associated with mild traumatic brain injury, otherwise known as concussion.
2024: Abbott bumps up profit forecast on strong medical device sales
2024: Abbott CEO sees ‘mass market potential’ for CGMs
2024: Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline
2024: Abbott Laboratories: Driving Value By Scaling Innovations
2024: Abbott Laboratories: The Fantastic Mix Of Growth And Value - At A Great Price_ seekingalpha.com
2024: Abbott Labs' Reversal Is Here - CGM Tailwinds In 2024
2024: Abbott Q3: Strong Growth In Medical Device And Pharma
2024: Abbott, iCardio.ai partner on AI for electrophysiology imaging
2024: Abbott: Strong R&D Pipeline Continues To Drive Growth, Reiterate 'Strong Buy'
2024: Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
2024: Army Announces FDA Clearance of Whole Blood Rapid Test to Help with Assessment of Traumatic Brain Injury
2024: The King Is Back: Abbott Laboratories' Path To >11% Annual Returns
2024: Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
2025: A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
2025: Abbott Laboratories Basking In A Sharp Turn In Sentiment
2025: Abbott Laboratories Q4 2024 Earnings Preview
2025: Abbott Laboratories: FreeStyle Libre CGMs And EPD Business Driving Positive Momentum
2025: Abbott Laboratories: Strong Q4 Results And Bullish Outlook
2025: Abbott Laboratories: Why Wall Street's Skepticism Misses The Real Story
2025: Abbott Labs Stock Jumps on Strong Earnings, With $500M Investment in US Facilities
2025: Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees
2025: New data supports Abbott Volt pulsed field ablation system
2025: The Growth Of Medical Devices Needs To Continue In Order To Invest In Abbott
2025: Why Abbott Laboratories (ABT) is Among the Best Medical Device Stocks to Buy Now
2026: Abbott Earns FDA Authorization for Dual Glucose-Ketone Sensing Diabetes Tech
2026: Abbott Laboratories: A Dividend Aristocrat With A Compelling Valuation And Return Potential
2026: Blood tests could transform cancer screening soon : NPR
2026: Multi-Cancer Early Detection Goes Global and Gets Personal
Products: Abbot
TBI
Jumps
*Key People: Abbott
Finance & Acquisitions: Abbott